JENNIFER HULS: Open Payments
NPI 1659914257 · QUEEN CREEK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 38 payments from 12 companies in 2025. Trend: 2023 $14 · 2024 $276 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $506 |
| Novartis Pharmaceuticals Corporation | 6 | $132 |
| Genentech USA, Inc. | 3 | $91 |
| GENZYME CORPORATION | 4 | $84 |
| Grifols USA, LLC | 2 | $46 |
| BioCryst US Sales Co., LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Pharming Healthcare, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
Products named: AIRSUPRA, FASENRA, DUPIXENT, Xolair, Xembify, Rhapsido, ORLADEYO, TAKHZYRO.
Industry payments across AZ — which companies pay providers there.
